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Abstract
Background: The incidence of tuberculosis (TB) remains high among Chinese Uygurs (a long-dwelling ethnic
minority in Xinjiang) in China and the variants in IL-23R likely contribute to individual’s diversity in host response
during infection.
Methods: A hospital based one to one matched case–control study was performed to assess the role of single
nucleotide polymorphisms (SNPs) and copy number variation (CNV) of IL-23R in susceptibility and clinical features of
pulmonary TB in Chinese Uygurs. Thirteen SNPs in IL-23R were genotyped by multiplex SNaPshot and a CNV was
analyzed using Taqman real-time PCR in 250 pairs of pulmonary TB patients and controls.
Results: The SNP rs7518660 (OR = 4.78, 95 % CI 3.14–8.52) and the CNV in IL23R (OR = 2.75, 95 % CI 1.51–4.98) were
significantly associated with susceptibility to pulmonary TB. The SNP rs11465802 (OR = 3.23, 95 % CI 1.85–5.62) was
significantly associated with drug-resistance and the SNP rs1884444 (OR = 3.61, 95 % CI 1.90–6.85) was significantly
related to cavitary lesion in Chinese Uygurs.
Conclusions: Our study shows for the first time that SNP and CNV in IL23R were associated with susceptibility, drug
resistance and cavity formation of pulmonary TB. Our findings indicate that these IL-23R polymorphisms may be
considered as risk factors for active pulmonary TB and its severe clinical forms.
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Background
China has the world’s second largest tuberculosis (TB)
burden, accounting for 12 % of the global total cases in
2012 [1], and the Xinjiang Uygur Autonous Region
(Xinjiang) in northwestern China, has one of the highest
rates of incidence and mortality of TB in China [2–4].
The Chinese Uygur, one of the minority ethnic groups,
has higher prevalence of TB than the Chinese Han and
other Chinese minorities in Xinjiang, China [3], indicat-
ing that this group of people may be susceptible to TB.
The essential role of human genetic factors in suscep-
tibility to TB has been confirmed by twin studies [5],
linkage analysis [6], candidate gene association analysis
(reviewed in [7]) and genome-wide association studies
(GWAS) [8]. However, cumulative evidence suggests
that there is an ethnic difference in the polymorphisms
of candidate genes associated with TB susceptibility
[9, 10]. Thus, identification of variants of the genes
linked with TB susceptibility is still crucial for under-
standing both the mechanism underlying TB suscepti-
bility and gene function.
IL-23, a member of the IL-12 cytokine family, is a key
proinflammatory cytokine in innate and adaptive im-
mune systems. This cytokine plays a pivotal role in the
differentiation of the native CD4+ T cells into Th17 [11].
It has been shown that IL-17, mostly produced by Th17
cells, plays a crucial role in control of M. tuberculosis
infection [12]. Furthermore, IL-23 is required for long-
term control of M. tuberculosis [13]. The activity of IL-
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23 is mediated by its binding to IL23R complex, which is
composed of IL-12Rβ1 and IL-23R [14]. Recent studies
have shown that IL23R might also affect other
dependent cytokines, such as IL-1, IL-6 and tumor ne-
crosis factor (TNF) [15]. These cytokines are also critical
for the progression of tuberculosis [7, 16]. However,
there has been only one study showing one single nu-
cleotide polymorphism (SNP) in IL-23R was associated
with susceptibility to TB [17]. In addition, IL23R exhibits
a copy number variation (CNV) [18, 19], which could
contribute to individual’s diversity in host response dur-
ing infection and inflammation, and is possibly associ-
ated with TB.
A hospital based one to one matched case–control
study was conducted to determine whether the SNPs
and CNV of IL23R are associated with susceptibility and
clinical forms of pulmonary TB in Chinese Uygurs.
Methods
Study population
All participants were from Kashgar Prefecture, Xinjiang,
China. The area was selected due to the high incidence
of TB as well as the uniform ethnicity (with common
genetic background of Chinese Uygur [20]) and socio-
economic status. The ethnicity recording of all the
participants as Chinese Uygur were derived from their
self-declaration and checked by their identity (ID) card.
250 unrelated Uygur patients diagnosed with active pul-
monary TB at Kashgar Prefecture Chest Hospital were
enrolled from October 2013 to April 2014. Criteria for
inclusion as pulmonary TB cases were: 1) positive spu-
tum culture; 2) age range 18-75 years; 3) excluding those
with comorbidities such as lung carcinoma, asthma,
bronchiectasis, diabetes mellitus and other immunosup-
pressive conditions. Patients meeting all the criteria were
recruited. An equal number of age- (within 3 years) and
sex-matched Uygur healthy controls from the Health
Checkup Center of Kashgar Prefecture People’s Hospital
were enrolled during the same period. Those controls
were negative both for history of TB and T. SPOT. TB
assay. All participants had BCG vaccination and were
HIV seronegative.
The protocol was approved by the Ethics Committee
of The First Affiliated Hospital of Xinjiang Medical Uni-
versity, Urumqi, China. Written informed consents were
obtained from all participants.
Clinical features of pulmonary TB including drug resist-
ance of the strain, elapsed time to sputum culture conver-
sion, pulmonary infiltration and cavitary lesion were
reviewed as well as age, gender, body measure index
(BMI), smoking status and education background possibly
to be risk factors for developing pulmonary TB. The cul-
ture, identification and drug sensitivity test of M. tubercu-
losis strains were performed according to the national
criteria in China [21]. Four first-line anti-TB drugs (isonia-
zid, rifampicin, ethambutol, and streptomycin) and seven
second-line anti-TB drugs (Paminosalicylicacid, Ofloxacin,
Capreomycin, Amikacin, Kanamycin, Ethionamide, and
Cycloserine) were adopted to detect drug resistance, as
described elsewhere [22]. Drug sensitivity was defined as
sensitivity to all the tested drugs and drug resistance as re-
sistance to at least one tested drug, as described elsewhere
[23]. Pulmonary infiltration and cavity were evaluated on
the basis of chest CT scanning obtained at the beginning
of the treatment, which was read by independent phys-
ician not affiliated with the study. Pulmonary infiltration
on chest CT scanning was divided into two categories,
one involving one third or less of one lung, and the other
involving more than that. The commercially available T.
SPOT. TB assay (Oxford Immunotec, Abingdon, UK) was
performed to exclude latent M. tuberculosis infection
(LTBI) in controls, due to some candidate genes being re-
lated to TB as well as LTBI [24].
Genomic DNA extraction and marker selection
Genomic DNA was extracted from peripheral blood
mononuclear cells (PBMCs) of the samples with the
TIANamp blood Genomic DNA kit (Tiangen, Beijing,
China).
To confirm SNPs in Chinese Uygurs, we initially se-
quenced all 11 exons of IL-23R using ABI 3730 DNA
Analyzer (Additional file 1: Figure S1A) in 10 pairs of
samples, with each exon flanked with partial intronic se-
quences. The primers were designed by Primer 5.0 soft-
ware (Additional file 2: Table S1). Thirteen common SNPs
were identified in those regions and all were selected for
further genotyping (Additional file 3: Table S2). The CNV
in exon 11 of IL23R demonstrated previously [19] was se-
lected for further analysis.
SNP genotyping and copy number measurement
SNP genotyping was performed by the multiplex SNaP-
shot technique (Additional file 1: Figure S1B). In brief,
the primers and probes were designed by Primer 5.0
software (Additional file 4: Table S3). Multiplex PCR
products amplified by HotStarTaq (Qiagen) were puri-
fied with shrimp alkaline phosphatase (SAP) (Promega,
Madison, USA) and Exonuclease I (ExoI) (Epicentre,
Madison, USA). The purified Multiplex PCR products
were then used as templates for a minisequencing exten-
sion reaction using the SNaPshot Multiplex kit (Applied
Biosystems, Carlsbad, CA, United States). The SNaPshot
PCR products were also purified by SAP, and then de-
tected by capillary electrophoresis on an ABI 3130XL
DNA Analyzer (Applied Biosystems). The call rate per
SNP exceeded 98 %. The CNV in IL-23R of all partici-
pants was determined by Taqman real-time PCR, as de-
scribed elsewhere [19]. The call rate for copy number
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measurement reached 100 %. Furthermore, Accucopy
assay [25] and droplet digital PCR (ddPCR) [26] were
used to validate the copy number of 25 pairs randomly
selected from those tested samples (Additional file 5:
Figure S2 and Additional file 6: Figure S3), which ac-
count for 10 % of the total samples.
Statistical analysis
Continuous variables were compared using the Student’s
t test. Hardy–Weinberg equilibrium (HWE) was assessed
for all SNPs by χ2 goodness of fit test or Fisher’s exact
test. SNPs that deviated from the HWE (P < 0.05) or had
frequencies of variants of < 5 % in the control group
were excluded. Linkage disequilibrium blocks were
structured and haplotype frequencies were calculated
using Haploview version 4.2 (Daly Lab at the Broad In-
stitute Cambridge, MA, United States). The Linkage Dis-
equilibrium (LD) between SNPs and CNV was
determined both at the genotype and haplotype levels in
the control group, also using Haploview version 4.2, as
described elsewhere [27]. The associations between pul-
monary TB and Il-23R polymorphisms were calculated
by conditional logistic regression analysis, for three dif-
ferent genetic models (dominant, recessive and additive),
then adjusted by covariants for all analyses. The associ-
ation of each polymorphism with pulmonary TB clinical
forms was confirmed by unconditional logistic regres-
sion. Bonferroni correction was applied for multiple test-
ing. All P values reported were two-tailed, and a level of
0.05 was considered statistically significant. Statistical
analysis was performed using SAS version 9.2 (SAS insti-
tute, Cary, NC, United States).
Results
This study consisted of 250 pulmonary TB cases and
250 controls, matched with age and sex. Males
accounted for 55.6 % and females 44.4 % in each
group. The age was 44.34 ± 14.17 years for cases and
47.34 ± 16.20 years for controls. Among those 250
pulmonary TB patients, there were 172 drug-sensitive
patients and 78 drug-resistant ones. In those 78 drug-
resistant pulmonary TB patients, there were 10
multidrug-resistant tuberculosis (MDR). There was no
significant difference in age, gender, smoking, alcohol
intake, presence of TB history of houshold or educa-
tion background between pulmonary TB patients and
controls. As expected, BMI showed significant differ-
ence between these two groups, demonstrating that
thin individuals (BMI < 18.5) (OR = 3.93, 95 % CI
2.71–5.71) are more likely to suffer from pulmonary
TB in Chinese Uygurs (Table 1).
Association of the IL-23R genotype and allele frequencies
with pulmonary tuberculosis
Genotype frequencies for 9 SNPs (rs1884444, rs11465770,
rs10889664, rs11465788, rs7518660, rs11465802,
rs11465804, rs11209016 and rs10889677) included were
in HWE in both case and control groups (P > 0.05),
whereas other 4 SNPs (rs6687620, rs2863212, rs7530511
and rs10889671) were excluded, due to their deviation
from HWE (P < 0.05) in the control group. Of the 9 SNPs
included initially, 3 SNPs (rs11465770, rs11465804 and
rs11209026) were also excluded, because of their frequen-
cies of variants of < 5 % in the controls. Finally, 6 SNPs
(rs1884444, rs10889664, rs11465788, rs7518660,
Table 1 Basic characteristics of the participants in the study
Characteristics Controls (N = 250) PTB Cases (N = 250) OR (95 % CI)
Age, year
Mean ± SD 47.34 ± 16.20 44.34 ± 14.17
Gender
Male : Female 139:111 139:111
BMI
<18.5 : ≥18.5 92:158 174:76 3.93 (2.71–5.71)
Smoking status
Smoker : No-smoker 9:241 5:245 0.55 (0.18–1.65)
Alcohol intake status
Drinker : No-drinker 12:238 8:242 0.66 (0.26–1.63)
Presence of TB history of houshold
Presence : Absence 24:226 36:224 1.51 (0.87–2.62)
Education background
Junior high school or below : Senior high school or above 116:134 124:126 1.14 (0.80–1.62)
PTB pulmonary tuberculosis, OR odds ratio, CI confidence interval, SD standard deviation, BMI body measure index
The ethnicity recording of the study population as Chinese Uygur were derived from their self-declaration and checked by their identity (ID) card
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rs11465802 and rs10889677) were included for further
analysis.
The SNP rs7518660 (AA vs GG, OR = 12.73, 95 % CI
7.16–22.6; AG vs GG, OR = 2.99, 95 % CI 1.87–4.79;
AA + AG vs GG, OR = 4.78, 95 % CI 3.14–8.52) showed
significant association with pulmonary TB susceptibility
(Table 2, Table 3). The genotypes distribution frequen-
cies of rs10889677 (CC vs AA OR = 1.85, 95 % CI 1.13–
3.05) showed significant difference between the PTB
cases and controls (Table 2). However, after adjusting for
the covariant of BMI, there was no association between
rs10889677 (CC + AC vs AA OR = 0.88, 95 % CI 0.42–
1.23) and pulmonary TB (Table 3). There was moderate
to high LD in the control group between these 2 SNPs
(r2 = 0.59, D' = 0.96). There was also moderate to high
LD in controls between rs7518660 and rs11465802 (r2 =
0.59, D' = 0.97), and high LD between rs10889677 and
rs11465802 (D' = 0.97) (Fig. 1). Unexpectedly, there was
no association between rs11465802 and susceptibility to
pulmonary TB in Chinese Uygurs. The alleles of
rs7518660 (OR = 3.56, 95 % CI 2.74–4.62) and
rs10889677 (OR = 1.37, 95 % CI 1.07–1.76) also showed
Table 2 Genotype and allele frequencies distribution of IL-23R polymorphisms between controls and cases
dbSNP ID/CNV Genotype/Allele Controls n (%) PTB cases n (%) OR (95 % CI)
rs1884444 TT 82 (33.1) 87 (34.8) 1
GT 122 (49.2) 114 (45.6) 0.88 (0.59–1.31)
GG 44 (17.7) 49 (19.6) 1.05 (0.63–1.74)
T 286 (57.7) 288 (57.6) 1
G 210 (42.3) 212 (42.4) 1.00 (0.78–1.29)
rs10889664 CC 93 (37.5) 103 (41.2) 1
CT 117 (47.2) 109 (43.6) 0.84 (0.57–1.23)
TT 38 (15.3) 38 (15.2) 0.90 (0.53–1.53)
C 303 (61.1) 315 (63.0) 1
T 193 (38.9) 185 (37.0) 0.92 (0.71–1.19)
rs11465788 TT 85 (34.7) 87 (34.9) 1
CT 120 (49.0) 114 (45.8) 0.93 (0.63–1.38)
CC 40 (16.3) 48 (19.3) 1.17 (0.70–1.96)
T 290 (59.2) 288 (57.8) 1
C 200 (40.8) 210 (42.2) 1.06 (0.82–1.36)
rs7518660 GG 105 (42.3) 33 (13.2) 1
AG 116 (46.8) 109 (43.6) 2.99 (1.87–4.79)
AA 27 (10.9) 108 (43.2) 12.73 (7.16–22.6)
G 326 (65.7) 175 (35.0) 1
A 170 (34.3) 325 (65.0) 3.56 (2.74–4.62)
rs11465802 CC 74 (30.0) 70 (28.0) 1
AC 121 (49.0) 121 (48.4) 1.06 (0.70–1.60)
AA 52 (21.0) 59 (23.6) 1.20 (0.73–1.97)
C 269 (54.5) 261 (52.2) 1
A 225 (45.5) 239 (47.8) 1.10 (0.85–1.41)
rs10889677 AA 76 (30.9) 57 (22.9) 1
AC 119 (48.4) 121 (48.6) 1.36 (0.89–2.08)
CC 51 (20.7) 71 (28.5) 1.85 (1.13–3.05)
A 271 (55.1) 235 (47.2) 1
C 221 (44.9) 263 (52.8) 1.37 (1.07–1.76)
CNV CN < 2 3 (1.2) 7 (2.8) 2.66 (0.68–10.41)
CN = 2 230 (92.0) 202 (80.8) 1
CN > 2 17 (6.8) 41 (16.4) 2.75 (1.51–4.98)
PTB pulmonary tuberculosis, OR odds ratio, CI confidence interval, CNV copy number variation, CN copy number
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significant difference between the cases and the controls
(Table 2).
Association of IL-23R CNV with pulmonary TB
We initially sequenced 11 exons of IL23R from 10 pair
of samples. However, we did not find the CNV reported
previously [19] in those subjects. Given the much lower
frequency distribution of CNV compared to SNPs [28]
and the small sample size we selected, the negative result
was reasonable. Taking this into consideration, we still
further identified the CNV using Taqman real-time PRC
in 250 pairs of samples.
Delta Ct value of IL23R for each sample was calcu-
lated by normalizing with the Ct value of RnaseP
Table 3 Association of IL-23R SNPs genotypes with pulmonary TB under different genotype models
dbSNP ID Allele Genetic Model OR (95 % CI) ORc (95 % CI) ORa (95 % CI)
rs1884444 T > G Dominant 1.08 (0.75–1.56) 1.12 (0.83–1.77) 1.22 (0.89–1.83)
Recessive 1.17 (0.72–1.79) 1.21 (0.77–1.84) 1.33 (0.79–1.94)
Additive 0.86 (0.61–1.23) 0.91 (0.81–1.34) 0.93 (0.85–1.46)
rs10889664 C > T Dominant 1.16 (0.81–1.67) 1.22 (0.90–1.83) 1.31 (0.94–1.92)
Recessive 0.86 (0.62–1.65) 0.89 (0.72–1.88) 0.95 (0.76–1.97)
Additive 1.16 (0.81–1.64) 1.34 (0.93–1.77) 1.54 (0.95–1.83)
rs11465788 T > C Dominant 0.99 (0.68–1.43) 1.02 (0.74–1.65) 1.23 (0.82–1.75)
Recessive 1.22 (0.77–1.30) 1.24 (0.82–1.43) 1.37 (0.85–1.55)
Additive 0.88 (0.62–1.25) 0.93 (0.81–1.38) 0.95 (0.86–1.43)
rs7518660 G > A Dominant 4.83 (3.10–7.53) 4.91 (3.25–8.17) 4.78 (3.14–8.52)
Recessive 6.25 (3.85–10.00) 6.54 (3.62–10.34) 6.38 (3.51–10.46)
Additive 0.88 (0.62–1.25) 0.91 (0.58–1.36) 0.93 (0.65–1.47)
rs11465802 C > A Dominant 0.91 (0.62–1.33) 0.95 (0.57–1.46) 1.01 (0.48–1.52)
Recessive 1.16 (0.60–1.75) 1.23 (0.54–1.86) 1.45 (0.76–1.92)
Additive 1.02 (0.72–1.46) 1.14 (0.65–1.57) 1.26 (0.63–172))
rs10889677 A > C Dominant 0.66 (0.44–0.99) 0.72 (0.39–1.12) 0.88 (0.42–1.23)
Recessive 1.53 (1.01–2.31) 1.61 (0.99–1.98) 1.75 (1.05–2.03)
Additive 1.01 (0.71–1.43) 1.15 (0.68–1.74) 1.24 (0.73–1.82)
OR odds ratio, CI confidence interval
OR for comparison of genetic models by conditioned logistic regression analysis
ORc = OR value after Bonferroni correction
ORa = OR value adjusted for BMI
Fig. 1 Linkage Disequilibrium Plot of SNPs of IL-23R in the control group. Linkage disequilibrium (LD) blocks in the IL23R polymorphisms black
squares indicate significant allelic association between groups of SNPs from the control subjects measured by the D' (left panels) and r2 (right
panels) statistics. A D' or r2 cutoff of 0.8 is used for LD. High D' values are dark, low D' values are light
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(Additional file 1: Figure S1C). Copy number was
then transferred from the Delta Ct value. The copy
number frequency distribution of IL-23R showed a
significant difference (P = 0.001) between controls and
cases (Fig. 2). The further analysis showed that the
frequencies of copy number increase (OR = 2.75, 95 % CI
1.51–4.98) in patients were significantly higher than those
in controls (Table 2).
It is important to determine the degree of LD between
the CNV of IL-23R and rs7518660 and rs10889677,
given that these variants were all associated with suscep-
tibility to pulmonary TB in Chinese Uygurs. LD between
the CNV and these two SNPs was determined in the
control group at the haplotype level, using estimated
phased as well as genotype level. There was weak LD be-
tween the CNV and rs7518660 and rs10889677 in the
control group, as measured by r2 (r2 < 0.01), which was
not affected by the MAF of the haplotypes (Additional
file 7: Table S4).
We then used AccuCopy assay and ddPCR to validate
the copy number of IL-23R calculated by Taqman real-
time PCR with 25 pairs randomly selected from those
500 tested samples (Additional file 5: Figure S2 and
Additional file 6: Figure S3). The results both showed
98 % concordant. Due to the relatively small sample size,
we then calculated the power of the test. It is over 0.8,
meaning that the result is reliable.
Association of IL-23R haplotypes with pulmonary TB
Pairwise LD between the 6 SNPs of IL-23R was calcu-
lated by D' and r2 from controls (Fig. 1). Based on
the LD, 2 block haplotypes were constructed using
Haploview version 4.2. The common haplotypes (fre-
quency > 3 %) in each block accounted for 97.3 % and
96.4 % for the cases and 100 % and 97.5 % for the
controls. We found 5 haplotypes (GTC and GCC in
Block1; GAA, ACA and GAC in Block2) were sig-
nificantly associated (OR = 6.10, 95 % CI 4.99–7.47;
OR = 6.50, 95 % CI 4.36–9.71; OR = 1.97, 95 % CI
1.57–2.47; OR = 0.61, 95 % CI 0.44–0.85; OR = 6.76,
95 % CI 4.76–9.60, respectively) with pulmonary TB
(Table 4). Among these 5 haplotypes, ACA in Block2
was a protective factor for Pulmonary TB, while other
4 haplotypes were risk factors.
Association of IL-23R polymorphisms with clinical forms
of pulmonary TB
The SNP rs11465802 (AA + AC vs CC, OR = 3.23, 95 %
CI 1.85–5.62) showed significant association with drug
resistance of the strain and the SNP rs1884444 (GG +
GT vs TT, OR = 3.61, 95 % CI 1.90–6.85) demonstrated
significant association with cavitary formation on chest
CT scanning in Pulmonary TB patients. There were no
significant association between the polymorphisms of IL-
23R and conversion of sputum culture and pulmonary
infiltration in the pulmonary TB patients (Table 5,
Table 6).
Discussion
In the present study, we found that the SNP
rs7518660 and the CNV in exon 11 of IL-23R were
significantly associated with susceptibility to active
pulmonary TB, meanwhile, we observed that
rs11465802 was associated with drug-resistance and
rs1884444 was related to cavity formation in Chinese
Uygurs in China. To our knowledge, this is the first
report showing that the CNV of IL-23R are associated
with active pulmonary TB and the first association of
polymorphisms in IL-23R with drug-sensitivity and
cavitary lesion in pulmonary TB patients.
To date, the G1186A SNP in MRC1 [29] has been re-
ported to be associated with TB in Chinese Uygurs.
There was only one study reporting the only SNP
(rs11209026) of IL-23R associated with the development
of a severe form (extensive lung infiltration) of active
pulmonary TB in Tunisians [17]. Unfortunately, we
couldn’t analyze the association between this poly-
morphism with TB, because it was excluded from further
analysis due to its low minor allele frequency in the con-
trol group. The results indicate that there was ethnic dif-
ference of the SNP rs11209026 among different racial
groups.
One function of IL-23 mediated by IL-23R complex is
driving T cell differentiation toward Th17, which leads
to an increased release of other cytokines causing in-
flammation, such as IL-17 and TNF [12]. The exact
mechanisms how these polymorphisms regulate the
function of IL-23R is currently unclear. Both the SNPs
Fig. 2 Copy number frequencies distribution of IL-23R between
controls and pulmonary TB patients
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rs7518660 and rs11465802 are located in intron 7, and
they may influence the expression of IL-23R by regulat-
ing differential splicing [30].
The signals in gene expression from SNP and CNV
had little overlap, thus it is important to realize the link-
age of these two polymorphisms with gene expression
for understanding the mechanisms of susceptibility to
TB [28]. Furthermore, both M. tuberculosis and M.
leprae are intracellular bacteria, so the patients with TB
and leprosy may have a similar immune response. An
increase in the copy number of exon 11 in the IL23R
gene has been reported to be associated with the pauci-
bacillary form of leprosy [19]. Therefore, we propose a
hypothesis that the CNV of IL-23R, if present in Chinese
Uygurs, may be associated with sputum positive pul-
monary TB. The result supports our hypothesis that the
increase in the copy number of IL23R is associated with
pulmonary TB in the Chinese Uygur population. Inter-
estingly, there was weak LD between the CNV in exon
11 and rs7518660, which was significantly associated
with susceptibility to pulmonary TB in Chinese Uygurs.
It suggested that the CNV was an independent risk fac-
tor for pulmonary TB in contrast with SNPs among
Chinese Uygurs. However, a recent study found that
there was an association of CCL3L1 copy number with
TB in a northwestern Colombian population [31], but
not in African and Peruvian populations [32]. All these
data indicate that CNVs in some special genes may also
Table 4 Association between haplotypes frequencies of IL-23R and pulmonary TB susceptibility
Block Haplotypes Controls (%) PTB Cases (%) OR (95 % CI)
Block1
rs1884444 rs10889664 rs11465788 TCT 70.8 27.5 1
GTC 25.4 60.2 6.10 (4.99–7.47)
GCC 3.8 9.6 6.50 (4.36–9.71)
Block2
rs7518660 rs11465802 rs10889677 ACC 44.6 30.4 1
GAA 22.8 30.6 1.97 (1.57–2.47)
ACA 14.2 5.9 0.61 (0.44–0.85)
AAA 11.3 8.3 1.08 (0.78–1.48)
GAC 4.6 21.2 6.76 (4.76–9.60)
PTB pulmonary tuberculosis, OR odds ratio, CI confidence interval
Table 5 Association of IL-23R polymorphisms and drug-sensitivity and conversion of sputum culture in pulmonary TB patients
dbSNP ID/ Genotype Drug-sensitivity (N = 250) OR (95 % CI) Months of treatment for
Negative culture (N =250)
OR (95 % CI)
CNV Drug-sensitive Drug-resistant ≤2 months > 2 months
N = 172 n (%) N = 78 n (%) N = 195 n (%) N = 55 n (%)
rs1884444 TT 72 (41.9) 31 (39.7) 1 79 (40.5) 24 (43.6) 1
GG + GT 100 (58.1) 47 (60.3) 1.09 (0.63–1.88) 116 (59.5) 31 (56.4) 0.88 (0.48–1.61)
rs10889664 CC 85 (49.4) 38 (48.7) 1 96 (49.2) 27 (49.1) 1
TT + CT 87 (50.6) 40 (51.3) 1.03 (0.60–1.76) 99 (50.8) 28 (50.9) 1.01 (0.55–1.83)
rs11465788 TT 73 (42.1) 32 (41.0) 1 83 (42.6) 22 (40.0) 1
CC + CT 99 (57.9) 46 (59.0) 1.06 (0.62–1.83) 112 (57.4) 33 (60.0) 1.11 (0.60–2.05)
rs7518660 GG 8 (4.7) 4 (5.1) 1 9 (4.6) 3 (5.5) 1
AA + AG 164 (95.3) 74 (94.9) 0.90 (0.29–3.09) 186 (95.4) 52 (94.5) 0.84 (0.22–3.21)
rs11465802 CC 117 (32.0) 31 (60.3) 1 116 (59.5) 32 (58.2) 1
AA + AC 55 (68.0) 47 (39.7) 3.23 (1.85–5.62) 79 (40.5) 23 (41.8) 1.06 (0.58–1.94)
rs10889677 AA 37 (21.5) 16 (20.5) 1 41 (21.0) 12 (21.8) 1
CC + AC 135 (78.5) 62 (79.5) 1.06 (0.55–2.05) 154 (79.0) 43 (78.2) 0.95 (0.46–1.97)
CNV CN = 2 138 (80.2) 62 (79.5) 1 157 (80.5) 43 (78.2) 1
CN = 1, 3, 4 34 (19.8) 16 (20.5) 1.05 (0.54–2.04) 38 (19.5) 12 (21.8) 1.15 (0.56–2.40)
OR odds ratio, CI confidence interval
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be associated with susceptibility to TB, although the eth-
nic difference exists. CNV can have influence on gene
expression levels by altering gene dosage, disrupting
coding sequences or perturbing long-range gene regula-
tion [33, 34]. An increase in the copy number of IL-23R
coincided with a relatively higher fraction of memory T
cells [19], but the influence of the CNV in the exon 11
of IL23R on its expression level needs to be further
elucidated.
Among 250 clinical isolates of Mycobacterium tubercu-
losis, 172 isolates (68.8 %) were drug-sensitive and 78
(31.2 %) were resistant to at least one drug and 10 (4 %)
were multidrug-resistant (MDR), consistent with the pre-
vious epidemiological results [22]. Interestingly, we ob-
served that rs11465802 was significantly associated with
drug-resistance, whereas it was not related to susceptibil-
ity to pulmonary TB. To date, variants in the HLA-DRB1,
-DQB1 [23] and SLC11A1 [35] have shown association
with M. tuberculosis drug sensitivity. The results demon-
strate that human genetic factors are associated with the
development of drug resistance of the strain in pulmonary
TB patients. These data suggest that patients carrying par-
ticular gene polymorphisms may be incapable of acquiring
adequate immune response to M. tuberculosis, and thus
the infected bacteria is prone to develop drug resistance.
In addition, in this study, it was revealed that
rs1884444 was associated with cavity formation, while it
was unassociated with susceptibility to pulmonary TB or
drug-resistance. It was reported that SLC11A1 polymor-
phinisms were associated with the presence of cavitary
lesions among pulmonary TB patients [35, 36]. These re-
sults suggest that human gene polymorphisms may
affect their inflammatory response after the infection
with M. tuberculosis, and thus result in the severe patho-
logical lesion.
The IL-23/IL-17 pathway is mainly composed of IL-
23, its functional receptor complex (a combination of
IL-23R and IL-12Rβ1), the downstream cytokines (for
example, IL-17) and other key signal molecules such as
STAT4. This immune pathway and its constituent mo-
lecular members play crucial roles in autoimmune in-
flammatory disease pathogenesis [15]. In this study, we
found the SNP rs7518660 in IL-23R were associated with
pulmonary TB in the Chinese Uygurs. It has been re-
ported that polymorphisms in the IL-12 receptorβ1 gene
were associated with TB in Moroccan [37] and Japanese
populations [38], but not in Koreans [39]. The SNPs in
IL-17 F were associated with pulmonary TB in Chinese
Han [40] and northern Spain patients [41], but not in
north Indians [42]. In addition, the polymorphisms of
STAT4 promoter-region were reported to be associated
with pulmonary TB in a Moroccan population, which
might impact STAT4 expression [43]. All these findings
indicate that the IL-23/IL-17 pathway may be a key
pathway in charging M. tuberculosis infection [13], al-
though ethnic difference exists. Thus, further research
on the function of the IL-23/IL-17 pathway in pulmon-
ary TB is desired. The IL-23/IL-17 pathway was thought
to be an attractive target for experimental tuberculosis
therapies [44, 45]. Therefore, IL-23R, a key member in
Table 6 Association of IL-23R polymorphisms and pulmonary infiltration and cavitary formation in pulmonary TB patients
dbSNP ID/ Genotype Cavitary formation (N = 250) OR (95 % CI) Pulmonary infiltration (N = 250) OR (95 % CI)
No Cavity lesion Cavity lesion ≤ 1/3 of one lung >1/3 of one lung
N = 179 n (%) N = 71 n (%) N = 138 n (%) N = 112 n (%)
rs1884444 TT 88 (49.2) 15 (21.1) 1 58 (42.0) 45 (40.2) 1
GG + GT 91 (50.8) 56 (78.9) 3.61 (1.90–6.85) 80 (58.0) 67 (59.8) 1.08 (0.65–1.79)
rs10889664 CC 87 (48.6) 36 (50.7) 1 68 (49.3) 55 (49.1) 1
TT + CT 92 (51.4) 35 (49.3) 0.92 (0.53–1.59) 70 (50.7) 57 (50.9) 1.01 (0.61–1.66)
rs11465788 TT 74 (41.3) 31 (43.7) 1 57 (41.3) 48 (42.9) 1
CC + CT 105 (58.7) 40 (56.3) 0.91 (0.52–1.59) 81 (58.7) 64 (57.1) 0.94 (0.57–1.55)
rs7518660 GG 7 (4.1) 5 (7.0) 1 7 (5.1) 5 (4.5) 1
AA + AG 172 (95.9) 66 (93.0) 0.54 (0.17–1.75) 131 (94.9) 107 (95.5) 1.14 (0.35–3.71)
rs11465802 CC 72 (40.2) 30 (42.3) 1 56 (40.6) 46 (41.1) 1
AA + AC 107 (59.8) 41 (57.7) 0.92 (0.53–1.61) 82 (59.4) 66 (58.9) 0.98 (0.59–1.63)
rs10889677 AA 39 (21.8) 14 (19.7) 1 31 (22.5) 22 (19.6) 1
CC + AC 140 (78.2) 57 (80.3) 1.13 (0.57–2.25) 107 (77.5) 90 (80.4) 1.19 (0.64–2.19)
CNV CN = 2 144 (80.4) 56 (78.9) 1 109 (79.0) 91 (81.3) 1
CN = 1, 3, 4 35 (19.6) 15 (21.1) 1.10 (0.56–2.17) 29 (21.0) 21 (18.7) 0.87 (0.46–1.62)
OR odds ratio, CI confidence interval
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the IL-23/IL-17 pathway, also may be a potential target
molecule for the therapeutic management of
tuberculosis.
In our study, it was revealed that individuals with BMI
< 18.5 kg/m2 are more likely to suffer from pulmonary
TB in Chinese Uygurs. It was reported that TB incidence
increased exponentially as BMI (range 18.5–30 kg/m2)
decreased across a variety of settings with different levels
of TB burden, however, the dose–response relationship
was uncertain at BMI levels <18.5 kg/m2. There were
only a few studies reporting data on TB incidence for
people with BMI <18.5 kg/m2, but the results were in-
consistent. Lonnroth K et al. [46] and Cegielski JP et al.
[47] reported that people with BMI <18.5 kg/m2 in-
creased TB incidence compared with those with BMI
≥18.5 kg/m2(including normal BMI, overweight and
obesity). However, Hanrahan CF et al. [48] revealed that
people with BMI <18.5 kg/m2 didn’t increase TB inci-
dence compared with those with normal BMI (range
18.6-25 kg/m2) in HIV-infected adults.
Our study had several inherent limitations. Firstly, se-
lection bias arose in the observation, for it was con-
ducted using a hospital based case–control study.
Secondly, the sample size was relative small, although
the power of the test was over 0.8, the results were still
needed to be validated in a large sample size. Addition-
ally, because the patients were only limited to sputum
positive pulmonary TB individuals, we didn’t know the
association between those polymorphisms and sputum
negative ones. Finally, the controls were only defined as
those without LTBI. This study were conducted in TB-
endemic settings, therefore we assumed that all individ-
uals were exposed to TB. Given that the controls were
uninfected, it’s unclear whether an association implies
susceptibility for developing active pulmonary TB or just
acquisition of LTBI.
In fact, human genetic effect on TB susceptibility is
more complicated than many other diseases because of
the serious confounding effects of behavioral and envir-
onmental factors [49]. However, we did not find those
behavioral factors were associated with pulmonary TB,
as evidenced by smoking or drinking, possibly because
few participants smoke or drink due to the Muslim cus-
tom. Therefore, further study of confounding effects be-
tween IL-23/IL-17 pathway genes polymorphisms and
behavioral and environmental risk factors in other ethnic
groups is needed.
Conclusions
Our study showed for the first time that IL23R SNPs
and CNV are associated with susceptibility to pulmonary
TB. Our results also revealed a significant association of
IL23R SNPs with the severe clinical forms of pulmonary
TB in the Chinese Uygur population.
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